Join
Live feed
·
PRReleasevia Quantisnow
Aerpio Pharmaceuticals, Inc. logo

Aerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 Trial

ByQuantisnow·Wall Street's wire, on your screen.
ARPO· Aerpio Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARPO (Aerpio Pharmaceuticals, Inc.) and more on Quantisnow.